To see the other types of publications on this topic, follow the link: Metaxalone.

Journal articles on the topic 'Metaxalone'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Metaxalone.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Yamaguchi, Masayoshi, та Robert M. Levy. "Metaxalone Suppresses Production of Inflammatory Cytokines Associated with Painful Conditions in Mouse Macrophages RAW264.7 Cells in Vitro: Synergistic Effect with β-caryophyllene". Current Molecular Medicine 20, № 8 (2020): 643–52. http://dx.doi.org/10.2174/1566524020666200217102508.

Full text
Abstract:
Backgrounds and Objective: Inflammation is implicated in the pathogenesis of many diseases. Inflammatory cytokines with painful conditions are well known as biomarkers in human muscle pain, and they are produced by macrophages. Metaxalone is used as a skeletal muscle relaxant, but the mechanism by which metaxalone acts is unknown. This study was undertaken to investigate whether or not metaxalone exhibits an inhibitory effect on the activity of inflammatory macrophages in vitro. Methods: Mouse macrophage RAW264.7 cells were cultured in Dulbecco’s Modification of Eagle’s Medium containing 10% f
APA, Harvard, Vancouver, ISO, and other styles
2

Pallio, Giovanni, Angela D’Ascola, Luigi Cardia та ін. "MAO-A Inhibition by Metaxalone Reverts IL-1β-Induced Inflammatory Phenotype in Microglial Cells". International Journal of Molecular Sciences 22, № 16 (2021): 8425. http://dx.doi.org/10.3390/ijms22168425.

Full text
Abstract:
Experimental and clinical studies have suggested that several neurological disorders are associated with the occurrence of central nervous system neuroinflammation. Metaxalone is an FDA-approved muscle relaxant that has been reported to inhibit monoamine oxidase A (MAO-A). The aim of this study was to investigate whether metaxalone might exert antioxidant and anti-inflammatory effects in HMC3 microglial cells. An inflammatory phenotype was induced in HMC3 microglial cells through stimulation with interleukin-1β (IL-1β). Control cells and IL-1β-stimulated cells were subsequently treated with me
APA, Harvard, Vancouver, ISO, and other styles
3

&NA;. "Gabapentin/metaxalone overdose." Reactions Weekly &NA;, no. 1074 (2005): 9. http://dx.doi.org/10.2165/00128415-200510740-00025.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Lin, Hong-Liang, Tieh-Kang Wu, Yu-Ting Huang, and Shan-Yang Lin. "Studies on Cocrystal Formation of Metaxalone with Short-chain Dicarboxylic Acids." Acta Crystallographica Section A Foundations and Advances 70, a1 (2014): C658. http://dx.doi.org/10.1107/s2053273314093413.

Full text
Abstract:
A possible cocrystal formation between metaxalone and short-chain dicarboxylic acids (HOOC-(CH2)n-COOH, n=0-3) was quickly investigated using a solvent-assisted grinding approach. Differential scanning calorimetry (DSC), Fourier transform infrared (FTIR) microspectroscopy, and powder X-ray diffraction (PXRD) were used to verify the cocrystal formation between metaxalone and each dicarboxylic acid. A solvent evaporation method was used to prepare the standard cocrystal. The cocrystal formation was also estimated by using a one-step simultaneous DSC-FTIR microspectroscopy. The present study indi
APA, Harvard, Vancouver, ISO, and other styles
5

Sahu, Prafulla Kumar, M. Mathrusri Annapurna, and Sahoo Dillip Kumar. "Development and Validation of Stability Indicating RP-HPLC Method for the Determination of Metaxalone in Bulk and its Pharmaceutical Formulations." E-Journal of Chemistry 8, s1 (2011): S439—S447. http://dx.doi.org/10.1155/2011/645710.

Full text
Abstract:
A stability indicating reverse phase HPLC method was developed for the determination of metaxalone, a skeletal muscle relaxant, present in bulk and its pharmaceutical formulations using gliclazide as the internal standard (I.S). A hypersil ODS C18 column (250 × 4.6 mm, packed with 5 micron) in an isocratic mode with mobile phase Acetonitrile: phosphate buffer 3.6 (50:50%v/v) was used at a flow rate of 0.8 mL/ min and effluent was monitored at 225 nm. The assay exhibited a linear dynamic range of 0.6-100 µg/mL. Acceptable precision and accuracy were obtained for concentrations over the standard
APA, Harvard, Vancouver, ISO, and other styles
6

Nallakumar, P. *. and Siva Kumar R. "BIOANALYTICAL METHOD DEVELOPMENT, VALIDATION AND QUANTIFICATION OF METAXALONE BY LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY IN RAT PLASMA." Indo American Journal of Pharmaceutical Sciences 04, no. 07 (2017): 2128–38. https://doi.org/10.5281/zenodo.836457.

Full text
Abstract:
A simple, highly sensitive, precise and accurate high-performance liquid chromatographic (LCMSMS) method with mass detection was developed and validated for the rapid quantiication of metaxalone (CAS Registry No, 1665-48- 1) in rat plasma samples. The chromatographic separation was achieved with a reverse phase column Agilent XDB C18 (4.6×100 mm, 5µ) and the mobile phase consisted of methanol and 5 mm ammonium acetate buffer (80:20 v/v) as eluent, at a low rate of 0.6 mL/min. Phenytoin (CAS Registry no, 57-41-0) was used as an internal standard. The efluence was ionized by positive electrospra
APA, Harvard, Vancouver, ISO, and other styles
7

Ashish, Jain* Srushti Kadave Mukesh Patil Rupali Bothara Swati Borase. "Development and Validation of Metaxalone and Diclofenac Potassium in Bulk and Its Formulation using RP-HPLC Techniques." International Journal of Pharmaceutical Sciences 2, no. 12 (2024): 2120–31. https://doi.org/10.5281/zenodo.14481671.

Full text
Abstract:
This research article aims to develop and validate the Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) technique for the simultaneous determinations of Diclofenac potassium and Metaxalone in tablets and bulk. On an Eclipse plus C<sub>18</sub> (250 mm &times; 4.6 mm ID, 5&mu;m) column, chromatographic separation was accomplished with a mobile phase consisting of potassium dihydrogen phosphate buffer (pH 4.2): acetonitrile (30:70 v/v) at a flow rate of 1 ml/min. The detection wavelength was selected to be 280 nm. Diclofenac potassium and Metaxalone were shown to have retention per
APA, Harvard, Vancouver, ISO, and other styles
8

Moore, Karla A., Barry Levine, and David Fowler. "A fatality involving metaxalone." Forensic Science International 149, no. 2-3 (2005): 249–51. http://dx.doi.org/10.1016/j.forsciint.2004.07.017.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

&NA;. "Levetiracetam/metaxalone/neuropsychotherapeutics/opioids." Reactions Weekly &NA;, no. 1430 (2012): 21. http://dx.doi.org/10.2165/00128415-201214300-00073.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Gruszecki, Amy C., Susan Kloda, Gary T. Simmons, Thomas M. Daly, Robert W. Hardy, and C. Andrew Robinson. "Polydrug Fatality Involving Metaxalone." Journal of Forensic Sciences 48, no. 2 (2003): 2002286. http://dx.doi.org/10.1520/jfs2002286.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Poklis, J. L., J. D. Ropero-Miller, D. Garside, and R. E. Winecker. "Metaxalone (Skelaxin(R))-Related Death." Journal of Analytical Toxicology 28, no. 6 (2004): 537–40. http://dx.doi.org/10.1093/jat/28.6.537.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Gohel, Sunil Kumar, Vasanthi Palanisamy, Palash Sanphui, Muthuramalingam Prakash, Girij Pal Singh, and Vladimir Chernyshev. "Isostructural cocrystals of metaxalone with improved dissolution characteristics." RSC Advances 11, no. 49 (2021): 30689–700. http://dx.doi.org/10.1039/d1ra05959a.

Full text
Abstract:
Metaxalone forms isostructural cocrystals with nicotinamide and salicylamide that offer a solubility advantage compared to the native drug. A drug–drug homosynthon is retained in all the cocrystal structures.
APA, Harvard, Vancouver, ISO, and other styles
13

Forrester, Mathias B. "Adult metaxalone ingestions reported to Texas poison control centers, 2000-2006." Human & Experimental Toxicology 29, no. 1 (2009): 55–62. http://dx.doi.org/10.1177/0960327108098150.

Full text
Abstract:
Few data exist on potentially adverse metaxalone (Skelaxin®) ingestions in adults. All metaxalone ingestions involving patients aged ≥20 years during 2000-2006 were retrieved from Texas poison control centers. Exclusion criteria were lack of follow-up or multiple substance ingestion. Cases were analyzed for selected demographic and clinical factors. Of the 142 patients, 66.2% were female. Dose ingested was reported for 61 patients. Of those cases with a reported dose, distribution by management site was 29.5% on-site, 59.0% already at/en route to health care facility, and 11.5% referred to hea
APA, Harvard, Vancouver, ISO, and other styles
14

Bredikhin, Alexander A., Zemfira A. Bredikhina, and Aidar T. Gubaidullin. "Chirality-dependent supramolecular synthons based on the 1,3-oxazolidin-2-one framework: chiral drugs mephenoxalone, metaxalone and 114 other examples." CrystEngComm 22, no. 43 (2020): 7252–61. http://dx.doi.org/10.1039/d0ce00116c.

Full text
Abstract:
Analysis of the 119 crystal structures of 1,3-oxazolidin-2-one derivatives, including the chiral muscle relaxants mephenoxalone and metaxalone, showed that cyclic motifs dominate in racemic, and linear in single-enantiomeric, samples.
APA, Harvard, Vancouver, ISO, and other styles
15

Bosak, Adam R., and Aaron B. Skolnik. "Serotonin Syndrome Associated with Metaxalone Overdose." Journal of Medical Toxicology 10, no. 4 (2014): 402–5. http://dx.doi.org/10.1007/s13181-014-0404-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Curtis, B., C. Jenkins, and A. L. Wiens. "A Rare Fatality Attributed Solely to Metaxalone." Journal of Analytical Toxicology 39, no. 4 (2015): 321–23. http://dx.doi.org/10.1093/jat/bkv008.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Aitipamula, Srinivasulu, Pui Shan Chow, and Reginald B. H. Tan. "Conformational Polymorphs of a Muscle Relaxant, Metaxalone." Crystal Growth & Design 11, no. 9 (2011): 4101–9. http://dx.doi.org/10.1021/cg200678e.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Bishop-Freeman, Sandra C., Alison Miller, Erin M. Hensel, and Ruth E. Winecker. "Postmortem Metaxalone (Skelaxin®) Data from North Carolina." Journal of Analytical Toxicology 39, no. 8 (2015): 629–36. http://dx.doi.org/10.1093/jat/bkv066.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Gohel, SunilKumar V., Palash Sanphui, Girij Pal Singh, Krishnamurthy Bhat, and Muthuramalingam Prakash. "Lower melting pharmaceutical cocrystals of metaxalone with carboxamide functionalities." Journal of Molecular Structure 1178 (February 2019): 479–90. http://dx.doi.org/10.1016/j.molstruc.2018.10.039.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Cherrington, Brett, Ulrich Englich, Supa Niruntari, William Grant, and Michael Hodgman. "Monoamine oxidase A inhibition by toxic concentrations of metaxalone." Clinical Toxicology 58, no. 5 (2019): 383–87. http://dx.doi.org/10.1080/15563650.2019.1648815.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Antil, Sunny, and Chitra Gupta. "Formulation and Evaluation of Nanoemulsion for Bioavailability Enhancement of Metaxalone." International Journal of Current Research and Review 13, no. 14 (2021): 47–53. http://dx.doi.org/10.31782/ijcrr.2021.131438.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Lee, Chen-An, Muoi Tang, Sheau-Ling Ho, and Yan-Ping Chen. "Solubilities of chlormezanone, metaxalone and methocarbamol in supercritical carbon dioxide." Journal of Supercritical Fluids 85 (January 2014): 11–16. http://dx.doi.org/10.1016/j.supflu.2013.10.006.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Tiwari, Ashutosh, Puja Bag, Mrinmoy Sarkar, Viney Chawla, and Pooja A. Chawla. "Formulation, validation and evaluation studies on metaxalone and diclofenac potassium topical gel." Environmental Analysis Health and Toxicology 36, no. 1 (2021): e2021001. http://dx.doi.org/10.5620/eaht.2021001.

Full text
Abstract:
Twenty different batches of gels containing metaxalone and diclofenac potassium were prepared for topical application. These drugs act synergistically in the management of pain and inflammation. Gels were prepared by varying the type of gelling agent (ten batches each of hydroxyl propyl methyl cellulose and carbopol 934). The prepared gels were characterized and evaluated. Batch F7 emerged as the best batch on the basis of favourable pH, high drug content, homogeneity and drug release. HPLC (High-performance liquid chromatography) method validation of gel formulation was also carried out and t
APA, Harvard, Vancouver, ISO, and other styles
24

Kuykendall, Jim R., and Richard S. Rhodes. "Auditory hallucinations elicited by combined meclizine and metaxalone use at bedtime." Annals of Pharmacotherapy 38, no. 11 (2004): 1968–69. http://dx.doi.org/10.1345/aph.1e231.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Forrester, Mathias B. "Pediatric Metaxalone Ingestions Reported to Texas Poison Control Centers, 2000-2007." Pediatric Emergency Care 26, no. 1 (2010): 15–18. http://dx.doi.org/10.1097/pec.0b013e3181c330dc.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Surmaitis, Ryan M., Thomas M. Nappe, and Matthew D. Cook. "Serotonin syndrome associated with therapeutic metaxalone in a patient with cirrhosis." American Journal of Emergency Medicine 34, no. 2 (2016): 346.e5–346.e6. http://dx.doi.org/10.1016/j.ajem.2015.06.043.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Tiwari, Ashutosh, Puja Bag, Mrinmoy Sarkar, Viney Chawla, and Pooja A. Chawla. "Formulation, validation and evaluation studies on metaxalone and diclofenac potassium topical gel." Environmental Analysis Health and Toxicology 36, no. 1 (2021): e2021001. http://dx.doi.org/10.5620/eaht.2021001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Swain, Suryakanta, Prafulla Kumar Sahu, G. V. Siva Prasad, Jagadeesh Panda, and Y. L. N. Murthy. "RP-HPLC Method for Determination of Metaxalone Using Box- Behnken Experimental Design." Journal of Applied Biopharmaceutics and Pharmacokinetics 2, no. 2 (2015): 40–49. http://dx.doi.org/10.14205/2309-4435.2014.02.02.1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Bredikhin, Alexander A., Dmitry V. Zakharychev, Aidar T. Gubaidullin, and Zemfira A. Bredikhina. "Solid Phase Behavior, Polymorphism, and Crystal Structure Features of Chiral Drug Metaxalone." Crystal Growth & Design 18, no. 11 (2018): 6627–39. http://dx.doi.org/10.1021/acs.cgd.8b00874.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Hamilton, Victoria, Iryna Andrusenko, Jason Potticary, et al. "Racemic Conglomerate Formation via Crystallization of Metaxalone from Volatile Deep Eutectic Solvents." Crystal Growth & Design 20, no. 7 (2020): 4731–39. http://dx.doi.org/10.1021/acs.cgd.0c00497.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Roy, Shikha M. N., Kiran V. Mangaonkar, Santosh M. Yetal, and Santosh S. Joshi. "LC-MS-MS Method for Determination of Metolazone in Human Plasma." E-Journal of Chemistry 5, no. 3 (2008): 634–40. http://dx.doi.org/10.1155/2008/425974.

Full text
Abstract:
A rapid, sensitive and specific method for quantification of metolazone in human plasma using metaxalone as internal standard is described. Sample preparation involved a simple liquid-liquid extraction procedure. The extract was analyzed by high performance liquid chromatography coupled to electrospray tandem mass spectrometry (LC–MS–MS). Chromatography was performed isocratically on a 5 μm C18analytical column (50 mm × 4.6 mmi.d.) with buffer–acetonitrile 20:80 (v/v) as mobile phase. The response to metolazone was a linear function of concentration over the range 1.00 to 2000.00 ng mL-1. The
APA, Harvard, Vancouver, ISO, and other styles
32

Cacace, Janice, Eugene E. Reilly, and Anton Amann. "Comparison of the dissolution of metaxalone tablets (Skelaxin) usingUSP apparatus 2 and 3." AAPS PharmSciTech 5, no. 1 (2004): 29–31. http://dx.doi.org/10.1208/pt050106.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Goswami, Dipanjan, Arabinda Saha, Sanjay Gurule, Arshad Khuroo, Tausif Monif, and Poonam Vats. "Metaxalone estimation in biological matrix using high-throughput LC–MS/MS bioanalytical method." Journal of Chromatography B 902 (August 2012): 132–36. http://dx.doi.org/10.1016/j.jchromb.2012.05.034.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Cacace, Janice, Eugene E. Reilly, and Anton Amann. "Comparison of the dissolution of metaxalone tablets (Skelaxin) usingUSP apparatus 2 and 3." AAPS PharmSciTech 5, no. 1 (2004): 29–31. http://dx.doi.org/10.1007/bf02830574.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Zhang, Juan, Yi-Feng Liu, Bo Lan, and Xiao-Dong Fan. "Synthesis of dextran-metaxalone conjugates and study on their control drug release behaviors." Journal of Applied Polymer Science 107, no. 5 (2007): 3386–92. http://dx.doi.org/10.1002/app.27379.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Martini, Dyllon Ivy, Nicholas Nacca, David Haswell, Timothy Cobb, and Michael Hodgman. "Serotonin syndrome following metaxalone overdose and therapeutic use of a selective serotonin reuptake inhibitor." Clinical Toxicology 53, no. 3 (2015): 185–87. http://dx.doi.org/10.3109/15563650.2015.1009993.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Nirogi, R. V. S., V. N. Kandikere, M. Shukla, K. Mudigonda, W. Shrivastava, and P. V. Datla. "Quantification of Metaxalone in Human Plasma by Liquid Chromatography Coupled to Tandem Mass Spectrometry." Journal of Analytical Toxicology 30, no. 4 (2006): 245–51. http://dx.doi.org/10.1093/jat/30.4.245.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Hong, Minghuang, Shiwang Wu, Minghui Qi, and Guobin Ren. "Solubility correlation and thermodynamic analysis of two forms of Metaxalone in different pure solvents." Fluid Phase Equilibria 409 (February 2016): 1–6. http://dx.doi.org/10.1016/j.fluid.2015.09.013.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Gangurde, Prachi, Sandeep Sonawane, Sanjay Kshirsagar, and Santosh Chhajed. "Development and Validation of HPLC Method for the Estimation of Metaxalone in Spiked Human Plasma." Asian Journal of Pharmaceutical Analysis 9, no. 4 (2019): 210. http://dx.doi.org/10.5958/2231-5675.2019.00035.8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Zhang, Juan, XiaoDong Fan, YiFeng Liu, Lan Bo, and Xiang Liu. "Synthesis of poly(ethylene glycol)–metaxalone conjugates and study of its controlled release in vitro." International Journal of Pharmaceutics 332, no. 1-2 (2007): 125–31. http://dx.doi.org/10.1016/j.ijpharm.2006.09.039.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Roy, S. M. N., S. M. Yetal, V. V. Vaidya, and S. S. Joshi. "Determination and Quantification of Phenytoin in Human Plasma by Liquid Chromatography with Electrospray Ionization Tandem Mass Spectrometry." E-Journal of Chemistry 5, no. 1 (2008): 169–76. http://dx.doi.org/10.1155/2008/362512.

Full text
Abstract:
A rapid and simple high pressure liquid chromatography method with mass spectrometry detection was developed and validated for the determination of phenytoin in human plasma. Metaxalone was used as internal standard. The sample preparation involves a rapid and simple procedure based on liquid-liquid extraction. Analysis was performed in less than 3.0 minutes in isocratic mode on a reversed phase C18column (5μ; 50 × 4.6 mm) using a mobile phase composed of acetonitrile-buffer 2 mM ammonium acetate (80:20v/v), pH of buffer adjusted to 3.4 using formic acid, at 0.4 mL min-1 flow rate. The calibra
APA, Harvard, Vancouver, ISO, and other styles
42

Reddy, N. V. Mahipal, B. Mohammed Ishaq*, V. S. Thiruvengada Rajan, and C. Gopinath. "ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF METAXALONE IN BULK AND ITS PHARMACEUTICAL FORMULATION BY UV SPECTROSCOPIC METHOD." International Research Journal of Pharmacy 4, no. 3 (2013): 149–52. http://dx.doi.org/10.7897/2230-8407.04329.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Marothu, Vamsi Krishna, Rajendra N. Dash, Saritha Vemula, Shravani Donkena, Ramesh Devi, and Madhavi Gorrepati. "Kinetics study of metaxalone degradation under hydrolytic, oxidative and thermal stress conditions using stability-indicating HPLC method." Journal of Pharmaceutical Analysis 2, no. 6 (2012): 431–36. http://dx.doi.org/10.1016/j.jpha.2012.08.004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Zhao, Lanting, Qian Li, Chang Shu, Keli Wang, and Li Ding. "Quantitative determination of metaxalone in human plasma by LC-MS and its application in a pharmacokinetic study." Asian Journal of Pharmaceutical Sciences 11, no. 5 (2016): 668–72. http://dx.doi.org/10.1016/j.ajps.2016.01.002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Friedman, Benjamin W., Eddie Irizarry, Clemencia Solorzano, et al. "A Randomized, Placebo-Controlled Trial of Ibuprofen Plus Metaxalone, Tizanidine, or Baclofen for Acute Low Back Pain." Annals of Emergency Medicine 74, no. 4 (2019): 512–20. http://dx.doi.org/10.1016/j.annemergmed.2019.02.017.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Panda, Sagar Suman. "New Stability-Indicating RP-HPLC Method for Determination of Diclofenac Potassium and Metaxalone from Their Combined Dosage Form." Scientia Pharmaceutica 80, no. 1 (2012): 127–37. http://dx.doi.org/10.3797/scipharm.1109-16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

TOTH, P., and J. URTIS. "Commonly used muscle relaxant therapies for acute low back pain: a review of carisoprodol, cyclobenzaprine hydrochloride, and metaxalone." Clinical Therapeutics 26, no. 9 (2004): 1355–67. http://dx.doi.org/10.1016/j.clinthera.2004.09.008.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Zhang, Juan, Yi-Feng Liu, Lin-Xue Liu, Ya-Zhou Zhang, Chang-An Qiao, and Yong-Zhu Zhou. "Poly[N-(2-hydroxypropyl)methacrylamide] prodrug for metaxalone via a chloroacetyl chloride linker: Synthesis and controlled release evaluation." Journal of Applied Polymer Science 125, no. 2 (2012): 1538–43. http://dx.doi.org/10.1002/app.36390.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Colaco, Socorrina, N. Ramesh, and Ramakrishna Shabaraya. "Demonstration of relative bioavailability of newly developed and innovator drug metaxalone 800 mg in healthy subjects under fed condition." Journal of Advanced Pharmaceutical Technology & Research 13, no. 2 (2022): 123. http://dx.doi.org/10.4103/japtr.japtr_362_21.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Lin, Hong-Liang, Tieh-Kang Wu, and Shan-Yang Lin. "Screening and characterization of cocrystal formation of metaxalone with short-chain dicarboxylic acids induced by solvent-assisted grinding approach." Thermochimica Acta 575 (January 2014): 313–21. http://dx.doi.org/10.1016/j.tca.2013.10.029.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!